BIONTECH SE

BNTX
Delayed Quote. Delayed  - 04/09 04:00:00 pm
122.14USD +6.68%
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2020 2021
Net sales1 4828 853
EBITDA1 -43,74 880
Operating profit (EBIT)1 -82,46 694
Operating Margin -17,1%75,6%
Pre-Tax Profit (EBT)1 -1469 972
Net income1 15,25 699
Net margin 3,15%64,4%
EPS2 0,0619,9
Dividend per Share2 --
Last update 03/30/202108/19/2020
1 EUR in Million
2 EUR
Estimates
Finances - Leverage
Fiscal Period: December 2020 2021
Net Debt1 --
Net Cash position1 1 1076 499
Leverage (Debt / EBITDA) 25,4x-1,33x
Free Cash Flow1 -79,55 721
ROE (Net Profit / Equities) 1,63%111%
Shareholders' equity1 9335 151
ROA (Net Profit / Asset) 0,98%117%
Assets1 1 5584 885
Book Value Per Share2 5,6817,5
Cash Flow per Share2 -0,059,09
Capex1 66,0154
Capex / Sales 13,7%1,74%
Last update 03/30/202104/06/2021
1 EUR in Million
2 EUR
Estimates
Balance Sheet Analysis
Financial Ratios
Size 2021e 2022e
Capitalization 24 788 M € -
Entreprise Value (EV) 18 289 M € 15 784 M €
Valuation 2021e 2022e
P/E ratio (Price / EPS) 5,16x 8,20x
Capitalization / Revenue 2,80x 4,28x
EV / Revenue 2,07x 3,16x
EV / EBITDA 3,75x 7,76x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 5,88x 4,14x
Profitability 2021e 2022e
Operating Margin (EBIT / Sales) 75,6% 74,9%
Operating Leverage (Delta EBIT / Delta Sales) 4,74x -1,02x
Net Margin (Net Profit / Revenue) 64,4% 58,2%
ROA (Net Profit / Asset) 117% 23,5%
ROE (Net Profit / Equities) 111% 28,5%
Rate of Dividend - -
Balance Sheet Analysis 2021e 2022e
CAPEX / Sales   1,74% 1,68%
Cash Flow / Sales 24,8% 3,18%
Capital Intensity (Assets / Sales) 0,55x 2,47x
Financial Leverage (Net Debt / EBITDA) - -
Price Earning Ratio
EPS & Dividend